- Patent Title: 2,3,5-substituted thiophene compound as protein kinase inhibitor
-
Application No.: US15998791Application Date: 2018-08-16
-
Publication No.: US10442796B2Publication Date: 2019-10-15
- Inventor: Tae Bo Sim , Woo Young Hur , Chi Man Song , Ho Jong Yoon , Seung Hye Choi , Han Na Cho , Hwan Geun Choi , Nam Doo Kim , Jung Beom Son , Eun Hwa Ko , Hyun Kyoung Kim , Joong Heui Cho , Seock Yong Kang , So Young Kim , Yi Kyung Ko , Seung Yeon Lee , Suk Kyoon Yoon , Jae Hyun Bae
- Applicant: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY , DAEGU-GYEONGBUK MEDICAL INNOVATION FOUNDATION
- Applicant Address: KR Seoul KR Daegu
- Assignee: Korea Institute of Science and Technology,Daegu-Gyeongbuk Medical Innovation Foundation
- Current Assignee: Korea Institute of Science and Technology,Daegu-Gyeongbuk Medical Innovation Foundation
- Current Assignee Address: KR Seoul KR Daegu
- Agency: Myers Bigel, P.A.
- Priority: KR10-2016-0017991 20160216
- Main IPC: C07D409/12
- IPC: C07D409/12 ; A61P35/02 ; A61K31/381 ; A61K31/4436 ; C07D333/10 ; C07D409/14
Abstract:
The present invention relates to a novel 2,3,5-substituted thiophene compound having inhibitory activity against kinases, an anticancer agent including the compound as an active ingredient, and a method for preparing the compound.
Public/Granted literature
- US20190047993A1 Novel 2,3,5-substituted thiophene compound as protein kinase inhibitor Public/Granted day:2019-02-14
Information query
